English
HomeGlenmark Pharmaceuticals gets ANDA approval for its anti
Aug 04, 2023
Send to us
LATEST NEWS
-
Rivaroxaban reduces adverse kidney events in atrial fibrillation patients with CKD
-
Wellbutrin vs. Lexapro: Which Is Right For You?
-
Efficacy of three antimicrobial mouthwashes in reducing SARS
-
Influence of rutin and its combination with metformin on vascular functions in type 1 diabetes
-
Extended Antidepressant Therapy Curbs Relapses in Bipolar Disorder